Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In clinical trials, adults taking Wegovy, together with eating fewer calories and being more active, achieved an average of 15% weight loss, and about 1 in 3 adults lost 20% of their body weight
They rediscover the joy of movement, the confidence to wear clothes they love, and the relief of reduced risk for chronic conditions
That's according to new research from the University of British Columbia showing that medications known as GLP-1 agonists - which includes brands like Wegovy, Ozempic, Rybelsus and Saxenda - are associated with an increased risk of serious medical conditions including stomach paralysis, pancreatitis and bowel obstruction
Supplementation Supplementing GLP-1 is a key way to reach adequate levels, which can be difficult through diet alone
Additional research will be needed to establish the effectiveness of GLP-1s in treating disordered eating
Zhang H, Wang M, He Y, Deng T, Liu R, Wang W, et al
